AZN
AstraZeneca PLC
NYSE · Healthcare · Drug Manufacturers - General · GB
$188.47
+2.50%Next report
Analyst consensus
- Next report date
- Feb 9, 2027
- EPS estimate
- $2.31
- Revenue estimate
- $16.6B
Latest reported
- Last report date
- Oct 30, 2026
- EPS actual
- $2.79
- EPS estimate
- $2.60
- Revenue actual
- $16.2B
- Revenue estimate
- $16.0B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +4.3%
- Revenue beats (12Q)
- 5
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 30, 2026 | $2.60 | $2.79 | Beat 7.31% | $16.2B |
| Jul 27, 2026 | $2.50 | $2.63 | Beat 5.20% | $15.4B |
| Apr 29, 2026 | $2.57 | $2.58 | Beat 0.39% | $15.3B |
| Nov 6, 2025 | $1.14 | $1.19 | Beat 4.39% | $15.2B |
| Jul 29, 2025 | $1.09 | $1.09 | In line | $14.5B |
| Apr 29, 2025 | $1.10 | $1.24 | Beat 12.73% | $13.6B |
| Feb 6, 2025 | $1.07 | $1.05 | Miss -1.87% | $14.9B |
| Jul 25, 2024 | $1.20 | $0.99 | Miss -17.50% | $12.9B |
| Apr 25, 2024 | $1.22 | $1.03 | Miss -15.37% | $12.7B |
| Feb 8, 2024 | $0.79 | $0.73 | Miss -7.36% | $12.0B |
| Nov 9, 2023 | $0.85 | $0.87 | Beat 2.11% | $11.5B |
| Jul 28, 2023 | $0.95 | $1.08 | Beat 13.45% | $11.4B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 9, 2027